Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
67.80
+0.76 (1.13%)
Oct 2, 2025, 3:45 PM EDT - Market open
Hologic Employees
Hologic had 7,063 employees as of September 30, 2024. The number of employees increased by 73 or 1.04% compared to the previous year.
Employees
7,063
Change (1Y)
73
Growth (1Y)
1.04%
Revenue / Employee
$571,839
Profits / Employee
$78,876
Market Cap
15.08B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 7,063 | 73 | 1.04% |
Sep 30, 2023 | 6,990 | 46 | 0.66% |
Sep 24, 2022 | 6,944 | 239 | 3.56% |
Sep 25, 2021 | 6,705 | 891 | 15.33% |
Sep 26, 2020 | 5,814 | -664 | -10.25% |
Sep 28, 2019 | 6,478 | 226 | 3.61% |
Sep 29, 2018 | 6,252 | 19 | 0.30% |
Sep 30, 2017 | 6,233 | 900 | 16.88% |
Sep 24, 2016 | 5,333 | 43 | 0.81% |
Sep 26, 2015 | 5,290 | -61 | -1.14% |
Sep 27, 2014 | 5,351 | -264 | -4.70% |
Sep 28, 2013 | 5,615 | -542 | -8.80% |
Sep 29, 2012 | 6,157 | 1,138 | 22.67% |
Sep 24, 2011 | 5,019 | 799 | 18.93% |
Sep 25, 2010 | 4,220 | 261 | 6.59% |
Sep 26, 2009 | 3,959 | 26 | 0.66% |
Oct 25, 2008 | 3,933 | 353 | 9.86% |
Nov 12, 2007 | 3,580 | 1,963 | 121.40% |
Nov 17, 2006 | 1,617 | 747 | 85.86% |
Nov 19, 2005 | 870 | 109 | 14.32% |
Nov 30, 2004 | 761 | 39 | 5.40% |
Nov 30, 2003 | 722 | -7 | -0.96% |
Nov 30, 2002 | 729 | -51 | -6.54% |
Nov 30, 2001 | 780 | -66 | -7.80% |
Nov 30, 2000 | 846 | 410 | 94.04% |
Nov 30, 1999 | 436 | 40 | 10.10% |
Nov 30, 1998 | 396 | 57 | 16.81% |
Nov 30, 1997 | 339 | 45 | 15.31% |
Nov 30, 1996 | 294 | 103 | 53.93% |
Nov 30, 1995 | 191 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
HOLX News
- 7 hours ago - Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis - Business Wire
- 2 days ago - New Survey Results Underscore the Need to #BustTheMyth About Mammograms - Business Wire
- 3 days ago - Volition Signs Co-Marketing and Services Agreement with Hologic - PRNewsWire
- 3 days ago - Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm - PRNewsWire
- 6 days ago - New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI - Business Wire
- 14 days ago - Blackstone and TPG revive interest in buying Hologic, source says - Reuters
- 23 days ago - Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference - Business Wire